This report expresses the author’s opinions. The author of this report has a short position in TCMD that will benefit from a decline in the price of TCMD’s securities. A full disclaimer can be found at the end of this report. This is a follow-on to our initial report published in June 2020. If youContinue reading “Strong Sell on Tactile Systems: Part II”
Author Archives: ossresearchteam
Strong Sell On Tactile Systems (TCMD): Bloated Stock Needs Compression Therapy
Strong Sell with 70% ($15 PT) downside: Un-chastened by the reality of a limited and saturated TAM, Tactile cheats to grow. VA, Medicare, and commercial payors are catching on. Insiders are jumping ship. It’s time for investors to wake up.